Author

G. Joshi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1 Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 4 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

P. Guchhait· 2 shared T. R. Asuru· 2 shared T. Shrivastava· 2 shared A. Abraham· 1 shared A. Chande· 1 shared A. Kumar· 1 shared A. Singh· 1 shared A.-K. Mehnert· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

P. Guchhait

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Hepatitis E Virus-induced antiviral response by plasmacytoid dendritic cells is modulated by the ORF2 protein

G. Joshi, E. Decembre, J. Brocard, C. Montpellier, M. Ferrie, O. Allatif, A.-K. Mehnert, J. Pons, D. Galiana, V. L. Dao Thi, N. Jouvenet, L. Cocquerel, M. Dreux

This study shows that Hepatitis E Virus (HEV) ORF2 protein modulates plasmacytoid dendritic cell (pDC)-mediated antiviral responses by affecting pDC recognition of infected cells.

bioRxiv · Apr 12, 2024Immunology

SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo

K. Jakhar, S. Sonar, G. Singh, T. R. Asuru, G. Joshi, N. Beniwal, T. Sarkar, M. Tiwari, J. Kaur, D. K. Rathore, B. Lal, S. Kumar, P. Srivastav, S. Kumar, V. Phagna, , S. Mani

The paper shows that SARS-CoV-2 spike antibodies can enhance DENV2 infection in vitro and in vivo, suggesting potential for increased dengue severity in COVID-19 survivors.

bioRxiv · Oct 9, 2023Immunology

Inhibition of BCR::ABL1 tyrosine kinase activity Aids in the Generation of Stable Chronic Myeloid Leukemia Induced Pluripotent Stem Cells

E. S. B. Benjamin, D. Babu, G. Joshi, B. M. Rajamani, K. Nandy, S. Rani, S. Anandhan, C. PremKumar, M. Maddali, A. Abraham, S. R. Velayudhan, P. Balasubramanian

This study generates stable CML-iPSCs by inhibiting BCR::ABL1 tyrosine kinase activity, enabling disease modeling and drug screening.

bioRxiv · Jun 1, 2023 · PreprintCancer Biology

Dietary αKG inhibits SARS CoV-2 infection and rescues inflamed lungs to restore normal O2 saturation in animals

S. Agarwal, S. Kaur, T. R. Asuru, G. Joshi, N. M. Shrimali, A. Singh, O. N. Singh, P. Srivastva, T. Shrivastava, S. Vrati, M. Surjit, P. Guchhait

This study shows dietary αKG inhibits SARS-CoV-2 infection and reduces lung inflammation and thrombosis in animals, restoring oxygen saturation.

bioRxiv · Apr 2, 2022 · PreprintPathology

B.1.617.3 SARS CoV-2 spike E156G/Δ157-158 mutations contribute to reduced neutralization sensitivity and increased infectivity

T. Mishra, G. Joshi, A. Kumar, R. Dalavi, P. Pandey, S. Shukla, R. K. Mishra, A. Chande

This study identifies spike mutations in B.1.617.3 SARS-CoV-2 variants that reduce neutralization sensitivity and increase infectivity.

bioRxiv · Oct 4, 2021 · PreprintMicrobiology